Clinical Trial Update: Asthmatic Subjects Could Live Without Short Acting beta2 Agonists

View source ↗

Summary

An update on a completed clinical trial indicating that asthmatic subjects could live without relying on short-acting beta-2 agonists (SABA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Universidad Nacional de Rosario | Conditions: Asthma Chronic | Status: COMPLETED